Jill DeSimone
InvestorDigital Pharma Advisor at Excelerate Health Ventures
Sarasota, Florida, United States
About
Former Merck Oncology President and biopharma board director.
Experience
- IndegeneFounder and Chair of Strategic Advisory Boardcurrent2023 — presentPrinceton, New Jersey, United States
- Praxis Precision Medicines, Inc.Independent Board Directorcurrent2022 — presentBoston, Massachusetts, United States
- JM DeSimone ConsultingFounder & Consulting Advisorcurrent2022 — presentSarasota, Florida, United States
- iTeos TherapeuticsIndependent Board Director2024 — 2025Waltham, Massachusetts, United States
- Affini-T TherapeuticsIndependent Board Director2022 — 2025Watertown, Massachusetts, United States
- Oncternal TherapeuticsIndependent Board Director2023 — 2025San Diego, California, United States
- Kinnate Biopharma Inc.Independent Board Director2023 — 2024San Francisco/San Diego
- MerckFormer President, U.S. Oncology | Established $9BN Leading Oncology Business2014 — 2022Pennsylvania
- Teva PharmaceuticalsSVP, Global Women’s Health | Created Teva’s 1st Global Business Unit from Multiple Acquisitions2012 — 2014Frazer, Pennsylvania, United States
- Bristol Myers SquibbSVP, U.S. Oncology, growth to over $2BN+ in Annual Revenue2010 — 2012Princeton, New Jersey, United States
- Bristol Myers SquibbSVP, U.S. Virology / HIV | Turned HIV Business Around to One of the leading HIV companies2006 — 2010Princeton, New Jersey, United States
Education
- Northeastern UniversityBachelor of Science - BS, Pharmacy
- The Wharton SchoolFellowship
Skills & more
Pharmaceutical Industry10Oncology12HIV Virology3Cardiology34Transformational Leadership3Executive Team Building3Organization Culture Design3Turnaround Management3Diversity & Inclusion3People Development3Talent Strategy2Fundraising2
+1 more
Board RecruitmentFrom Jill's professional profile.
Same school
Also attended Northeastern University211
Matt GuineyChief Financial Officer at Flybridge Capital PartnersSaunaz MoradiPartner, Communications at Lux CapitalBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Arjun BalajiPartner, Investing & Research at ParadigmAyesha AroraVenture Partner at S32
+ 205 more
Also attended The Wharton School1,323
Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures
+ 1,317 more
Shared employers
Also worked at Praxis Precision Medicines, Inc.2
Also worked at iTeos Therapeutics3
Also worked at Kinnate Biopharma Inc.3
Also worked at Merck90
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock Ventures
+ 84 more
Colleagues at Excelerate Health Ventures
Abhi Mehrotra
Digital Health Advisor at Excelerate Health Ventures
Adrienne Kirby
Digital Health Advisor at Excelerate Health Ventures
Al Peters
Digital Pharma Advisor at Excelerate Health Ventures
Andrew Bier
Digital Pharma Advisor at Excelerate Health Ventures
Andrew Schwab
Managing Partner at Excelerate Health Ventures
B. Bobby Bahram
Managing Partner at Excelerate Health Ventures
Bobby Bahram
Managing Partner at Excelerate Health Ventures
Bruce Boehm
Digital Health Advisor at Excelerate Health Ventures







.jpeg)




















